Company Overview - CollPlant Biotechnologies is a regenerative and aesthetic medicine company focused on developing technologies and products based on non-animal-derived recombinant human collagen (rhCollagen) [1][5] - The company aims to innovate in the fields of tissue repair, medical aesthetics, and organ manufacturing through its proprietary plant-based genetic engineering technology [5] Conference Participation - CollPlant will participate in the International Conference on Biofabrication 2025, scheduled for September 14–17, 2025, in Warsaw, Poland [1] - The company will have two presentations during the conference, showcasing its rhCollagen platform and biofabrication applications [2][7] Biofabrication and 3D Bioprinting - The conference will focus on advancements in biofabrication and bioprinting, which are crucial for medical research and the fabrication of complex scaffolds for tissue and organ engineering [2][4] - CollPlant's rhCollagen-based bioinks are highlighted for their controlled rheology, non-animal safety profile, biocompatibility, and tunable mechanical properties, making them suitable for high-fidelity 3D bioprinting [2] International Society for Biofabrication - The International Society for Biofabrication (ISBF) is a non-profit organization that promotes research and development in biofabrication, including 3D printing of tissues and regenerative medicine [3] - The ISBF organizes the annual International Conference on Biofabrication, which has grown to attract over 500 participants from various countries since its inception in 2006 [4]
CollPlant to Present at the 2025 International Conference on Biofabrication